Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs. Indeed, medicinal chemists face a challenge of their own. Trying to survive in a changing environment where pharma is focusing on biologics drug candidates will require chemists to adapt.
After four busy days of business sessions and meetings by members of the global chemical business community, the EPCA 50th Anniversary Annual Meeting has concluded with its annual closing lunch featuring Herman Van Rompuy, former President of the European Council (2009-2014) who outlined his views on the future with all the influences globalisation is having on the world, and what that means for Europe.
Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active pharmaceutical ingredients (APIs) and finished drug products.
